Recurrent duodenal ulcer haemorrhage: A pharmacoeconomic comparison of various management strategies

Expert Opinion on Pharmacotherapy

Volumn 4, Issue 9, 2003, Pages 1593-1603

  Ghoshal, Uday Chand ^a   Aggarwal, Rakesh ^a   Sreenivasa Baba, Chalamalasetty ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Bleeding peptic ulcer; Cost effectiveness; Gastrointestinal haemorrhage; Helicobacter pylori

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROTON PUMP INHIBITOR; SOMATOSTATIN; TINIDAZOLE;

ARTICLE; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; DATA ANALYSIS; DRUG COST; DUODENUM BLEEDING; ECONOMIC EVALUATION; ENDOSCOPIC THERAPY; ERADICATION THERAPY; HEALTH CARE COST; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOSPITAL; HUMAN; INDIA; MAINTENANCE THERAPY; MEDLINE; MORTALITY; QUALITY OF LIFE; RECURRENT DISEASE; SENSITIVITY ANALYSIS; ULCER HEALING;

CLINICAL TRIALS; COSTS AND COST ANALYSIS; DUODENAL ULCER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MODELS, ECONOMIC; PEPTIC ULCER HEMORRHAGE; PROTON PUMPS; QUALITY OF LIFE;

EID: 0141851851     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.4.9.1593     Document Type: Article

References (37)

1. SANDERS DS, CARTER MJ, GOODCHAP RJ, CROSS SS, GLESSON DC, LOBO AJ: Prospective validation of the Rockall risk scoring system for upper GI haemorrhage in subgroups of patients with varices and peptic ulcers. Am. J. Gastroenterol. (2002) 97:630-635.
2. INADOMI J, JOHANNES K, CELLO JP: Long-term follow-up of endoscopic treatment for bleeding gastric and duodenal ulcers. Am. J. Gastroenterol. (1995) 90:1065-1068.
3. GRAHAM DY, HEPPS KS, RAMIREZ FC, LEW GM, SAEED ZA: Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand. J. Gastroenterol. (1993) 28:939-942.
4. DUGGAN AE, TOLLEY K, HAWKEY CI, LOGAN RFA: Varying efficacy of Helicobacter pylori eradication regimens: cost-effectiveness study using decision analysis model. Br. Med. J. (1998) 316:1648-1655.
5. IMPARIALE TF, SPEROFF T, CEBUL RD, MCCULLOUGH AJ: A cost analysis of alternative treatment for duodenal ulcer. Ann. Intern. Med. (1995) 123:665-672.
6. GHOSHAL UC, DAS A: Management strategies for duodenal ulcer in India in the Helicobacter pylori era: an economic analysis. Natl. Med. J. India. (2002) 15:140-144.
7. KHUROO MS, YATTOO GN, JAVID G et al.: A comparison of omeprazole and placebo for bleeding peptic ulcer. N. Engl. J. Med. (1997) 336:1054-1058.
8. LIN HJ, LO WC, LEE FY, PERNG CL, TSENG GY: A prospective randomised comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch. Intern. Med. (1998) 158:54-58.
9. SANTANDER C, GRAVALOS RG, CEDENILLA AG, CANTERO J, PAJARES JM: Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent haemorrhage from peptic ulcer: prospective non-randomised trial of 125 patients. Am. J. Gastroenterol. (1996) 91:1549-1552.
10. JENSEN DM, CHENG S, THOMAS RN et al.: A controlled study of ranitidine for the prevention of recurrent haemorrhage from duodenal ulcer. N. Engl. J. Med. (1994) 330:382-386.
11. FENNERTY MB: What are the treatment goals for Helicobacter pylori infection? Gastroenterology (1997) 113:S120-S125.
12. BHASIN DK, SHARMA BC, RAY P, PATHAK CM, SINGH K: Comparison of seven and fourteen days of lansoprazole, clarithromycin and amoxycillin therapy for eradication of Helicobacter pylori: a report from India. Helicobacter (2000) 5:84-87.
13. OFMAN J, WALLACE J, BADAMGARAV E, CHIOU CF, HENNING J, LAINE L: The cost-effectiveness of competing strategies for the prevention of recurrent peptic ulcer haemorrhage. Am. J. Gastroenterol. (2002) 97:1941-1950.
14. IMPERIALE TF, BIRGISSON S: Somatostatin or octreotide compared with and placebo in the management of acute non-variceal upper gastrointestinal haemorrhage: a meta-analysis. Ann. Intern. Med. (1997) 127:1062-1071.
15. ROLLHAUSER C, FLEISCHER DE: Nonvariceal upper gastrointestinal bleeding. Endoscopy (2002) 34:111-118.
16. QASIM A, O'MORAIN CA: Review article: treatment of Helicobacter pylori infection and factors influencing eradication. Aliment. Pharmacol. Ther. (2002) 16:24-30.
17. GISBERT JP, GONZALEZ L, DE PEDRO A et al.: Helicobacter pylori and bleeding duodenal ulcer: prevalence of infection and role of non-steroidal anti-inflammatroy drugs. Scand. J. Gastroenterol. (2001) 36:717-724.
18. LEODOLTER A, KULIG M, BRASCH H, SABELLEK WM, WILLICH SN, MALFERTHEINER P: A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer. Aliment. Pharmacol. Ther. (2001) 15:1949-1958.
19. DOBRILLA G, PIAZZI L, FIOCCA R: Lansoprazole versus omeprazole for duodenal ulcer healing and prevention of relapse: a randomised, multicenter, double-masked trial. Clin. Ther. (1999) 21:1321-1332.
20. HOPKINS RJ, GIRARDI LS, TURNEY EA: Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gatroenterology (1996) 110:1244-1252.
21. JASPERSEN D, KOERNER T, SCHORR W, BRENNENSTUHI M, RASCHKA C, HAMMAR CH: Helicobacter pylori eradication reduces the rate of rebleeding in ulcer haemorrhage. Gastrointest. Endosc. (1995) 41:5-7.
22. ROKKAS T, KARAMERIS A, MAVROGEORGIS A et al.: Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest. Endosc. (1995) 41:1-4.
23. GROENEVELD PW, LIEU TA, FENDRICK MA et al.: Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia. Am. J. Gastroenterol. (2001) 96:338-347.
24. ADACHI M, MIZUNO M, YOKOTA K et al.: Reinfection rate following effective therapy against Helicobacter pylori infection in Japan. J. Gastroenterol. Hepatol. (2002) 17:27-33.
25. BAPAT MR, ABRAHAM P, BRANDARKAR PV, PHADKE AY, JOSHI AS: Acquisition of Helicobacter pylori infection and reinfection after its eradication are uncommon in Indian adults. Indian J. Gastroenterol. (2000) 19:172-174.
26. SPIEGEL BMR, OFMAN JJ, WOODS K, VAKIL NB: Minimizing recurrent peptic ulcer haemorrhage after endoscopic hemostasis: the cost-effectiveness of competing strategies. Am. J. Gastroenterol. (2003) 98:86-97.
27. LEE KC, YOU JHS, WONG ICK et al.: Cost-effectiveness analysis of high-dose omeprazole infusion as adjuvant therapy to endscopic treatment of bleeding peptic ulcer. Gastrointest. Endosc. (2003) 57:160-164.
28. SHERLOCK DJ, HOLL-ALLEN RT: Duodenal ulcer perforation whilst on cimetidine therapy. Br. J. Surg. (1984) 71:586-588.
29. SHARMA VK, SAHAI AV, CORDER FA, HOWDEN CW: Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage. Aliment. Pharmacol. Ther. (2001) 15:1939-1947.
30. LAI KC, HUI WM, WONG WM et al.: Treatment of Helicobacter pylori in patients with duodenal ulcer haemorrhage - a long-term randomised, controlled study. Am. J. Gastroenterol. (2000) 95:2225-2232
31. COLIN R, CZERNICHOW P, BATY V et al.: Low sensitivity of invasive tests for the detection of Helicobacter pylori infection in patients with bleeding ulcer. Gastroenterol. Clin. Biol. (2000) 24:31-35.
32. GARCIA-DIAZ E, CASTRO-FERNANDEZ M, ROMERO-GOMEZ M, VARGAS-ROMERO J: The effectiveness of (IgG-ELISA) serology as an alternative diagnostic method for detecting Heticobacter pylori infection in patients with gastrointestinal bleeding due to gastroduodenal ulcer. Rev. Esp. Enferm. Dig. (2002) 94:725-736.
33. SOLL AH: Medical treatment of peptic ulcer disease: practice guidelines. For the Practice Parameters Committee Of American College Of Gastroenterology. JAMA (1996) 275:622-629.
34. HIGHAM J, KANG JY, MAJEED A: Recent trend in admission and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects. Gut (2002) 50:460-464.
35. SONNENBERG A, OLSON CA, ZHANG J: The effect of antibiotic therapy on bleeding from duodenal ulcer. Am. J. Gastroenterol. (1999) 94:950-954.
36. UEMURA N, OKAMOTO S, YAMAMOTO S et al.: Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. (2001) 345:784-789.
37. BYTZER P, AALYKKE C, RUNE S et al.: Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. Scand. J. Gastroenterol. (2000) 35:1023-1032.